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1037the investigators on these important results. However, there are
some questions that need to be addressed in future research.
The investigators speculated that pulmonary congestion (although
they did not monitor this parameter in the study) and subsequent
stimulation of pulmonary irritant receptors might explain why
patients with CSA had an increase in minute ventilation and reduced
partial pressure of carbon dioxide via increased respiratory drive.
Therefore, the question that arises is why more ﬂuid goes to the
lungs in patients with CSA compared with patients with obstructive
sleep apnea (presumed to be the case because of opposite ﬁndings in
the study): is it related to a greater ﬂuid volume in cases of more
advanced heart failure? It is well known that the prevalence of CSA
increases with a greater severity of heart failure (2); thus, the presence
of CSA may simply reﬂect the degree of cardiac dysfunction.
Therefore, patterns of sleep apnea may change over time on the basis
of the status of cardiac performance.
Alternatively, other mechanisms yet to be elucidated may be
responsible for greater pulmonary congestion in patients with CSA.
Fluid overload and pulmonary congestion may explain why patients
with renal disease have a greater prevalence of CSA compared with
the general population (3). Therefore, it is important to study
whether pulmonary congestion and stimulation of pulmonary irri-
tant receptors will explain the different response to rostral ﬂuid shift
in patients with CSA and obstructive sleep apnea (4).*Aibek E. Mirrakhimov, MD
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Drs. Mirrakhimov and Mirrakhimov ask why more ﬂuid would be
redistributed in the lungs by application of lower body positive
pressure (LBPP) in patients with heart failure with central sleepapnea (CSA) than in those with obstructive sleep apnea, thus
stimulating pulmonary vagal irritant receptors that provoke
hyperventilation. They ask further whether this might be due to
a greater degree of volume overload in those with CSA.
In fact, we stated in the report that such differing responses may be
related to differing cardiac loading conditions (1). For example,
previous studies have shown that nonchemical pulmonary irritant
receptor stimulation by pulmonary congestion provokes hypocapnia
(2), that in patients with heart failure, partial pressure of carbon
dioxide is inversely proportional to left ventricular ﬁlling pressure (3),
and that reducing left ventricular ﬁlling pressure was associated with
attenuation of CSA (4). In our study, we observed that compared
with obstructive-dominant patients, central-dominant patients had
a much greater degree of mitral regurgitation, as well as higher right
ventricular systolic pressure and levels of N-terminal pro–B-type
natriuretic peptide, all of which are indicative of greater left
ventricular ﬁlling pressures and suggestive of greater pulmonary
congestion (5). Accordingly, for a similar ﬂuid shift from the legs into
the heart in response to LBPP, pulmonary congestion with stimu-
lation of vagal irritant receptors, a consequent increase in ventilation,
and a decrease in partial pressure of carbon dioxide would more likely
occur in patients with higher than in those with lower left ventricular
ﬁlling pressures. The signiﬁcant relationships between N-terminal
pro–B-type natriuretic peptide levels and indicators of increased
respiratory drive in response to LBPP further support this concept.
Drs. Mirrakhimov and Mirrakhimov also speculate that the type
of sleep apnea could change over time in response to alterations in
cardiac function. We agree, and in fact cited our previous work, in
which we demonstrated that the predominant type of sleep apnea
could shift from obstructive sleep apnea to CSA over time, in
association with a deterioration in cardiac function and a decrease
in partial pressure of carbon dioxide, and vice versa (6,7). We also
agree that ﬂuid overload and pulmonary congestion may explain the
higher prevalence of CSA in the renal failure population than in the
general population.
Finally, we concur with Drs. Mirrakhimov and Mirrakhimov
that future studies would ideally directly quantify lung water or left
ventricular ﬁlling pressure in response to interventions such as
LBPP and take us a step closer to deﬁning the mechanism for the
hyperventilatory response to LBPP observed in our patients with
heart failure with predominantly CSA.
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